Understanding how a specific RNA affects the virulence of Brucella bacteria

Elucidating the regulatory mechanism of a Brucella-specific small RNA required for virulence

NIH-funded research Virginia Polytechnic Inst and St Univ · NIH-11009545

This study is looking at a tiny piece of RNA called MavR to see how it helps Brucella bacteria cause infections in people and animals, with the hope of finding new ways to treat brucellosis, a disease that can be tough to manage.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionVirginia Polytechnic Inst and St Univ NIH-funded
Lab location1 site (Blacksburg, United States)
Project IDNIH-11009545 on NIH RePORTER

What this research studies

This research investigates the role of a small RNA, known as MavR, in the virulence of Brucella bacteria, which can cause serious infections in humans and animals. The study focuses on how this RNA regulates a key enzyme involved in bacterial cell wall synthesis, which is crucial for the bacteria's ability to survive and replicate within immune cells. By using animal models, the researchers aim to uncover the mechanisms behind Brucella's pathogenicity and explore potential new treatment strategies. This work could lead to better understanding and management of brucellosis, a disease that currently lacks effective vaccines and has high relapse rates after antibiotic treatment.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals who have been diagnosed with brucellosis or are at high risk of exposure to Brucella bacteria.

Not a fit: Patients who do not have brucellosis or are not at risk of exposure to Brucella bacteria may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for brucellosis and potentially new strategies to prevent infections caused by Brucella bacteria.

How similar studies have performed: Previous research has shown success in understanding bacterial virulence mechanisms, but the specific approach of targeting small RNAs in Brucella is relatively novel.

Where this research is happening

Blacksburg, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.